Winton Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-25,197
| Closed | -$227K | – | 1352 |
|
|
2021
Q3 | $227K | Sell |
25,197
-22,331
| -47% | -$201K | 0.01% | 1198 |
|
|
2021
Q2 | $569K | Buy |
47,528
+4,061
| +9% | +$48.6K | 0.03% | 841 |
|
|
2021
Q1 | $545K | Buy |
43,467
+11,654
| +37% | +$146K | 0.03% | 833 |
|
|
2020
Q4 | $496K | Buy |
31,813
+4,080
| +15% | +$63.6K | 0.04% | 795 |
|
|
2020
Q3 | $262K | Sell |
27,733
-62,032
| -69% | -$586K | 0.01% | 1284 |
|
|
2020
Q2 | $804K | Buy |
89,765
+59,597
| +198% | +$534K | 0.02% | 1055 |
|
|
2020
Q1 | $192K | Sell |
30,168
-77,374
| -72% | -$492K | 0.01% | 1264 |
|
|
2019
Q4 | $900K | Buy |
+107,542
| New | +$900K | 0.01% | 1096 |
|